Literature DB >> 11986341

Prevalence of antibodies to Chlamydia pneumoniae in an Israeli population without clinical evidence of respiratory infection.

M Ben-Yaakov1, G Eshel, L Zaksonski, Z Lazarovich, I Boldur.   

Abstract

AIMS: To estimate the occurrence of recent, past, and "persistent" infections with Chlamydia pneumoniae--as indicated by serology--in an Israeli population without clinical evidence of respiratory infection.
METHODS: Serum samples from 402 subjects (172 children and 230 adults), without known respiratory symptoms, were collected. Antibodies to C pneumoniae (IgG, IgA, and IgM) were evaluated using the microimmunofluorescence (MIF) assay. Antibody prevalence and indication of recent, past, and persistent infections were calculated and their distribution determined according to age, sex, and season.
RESULTS: Antibodies to C pneumoniae were detected in 53 children (31%) and 171 adults (74%). Recent infection was indicated in only one of 50 children under 5 years of age, in nine of 122 older children, and in 19 of 230 adults. IgM antibodies were detected in nine children, but only in three adults. Past infection was indicated in six of 96 young children (aged 1-10 years), in 28 of 76 teenagers, and in 128 of 230 adults. Persistent infection was indicated in three young children, in six teenagers, and in 24 adults, with a significantly higher frequency (p = 0.012) in men (18 of 117) than in women (six of 113). No seasonal differences could be detected.
CONCLUSIONS: Infection with C pneumoniae was detected serologically in children and adults without clinical signs of respiratory disease. These results should serve as a basis for studies on the role of C pneumoniae infections and their sequelae in Israel and contribute to the general understanding of asymptomatic infection with C pneumoniae.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11986341      PMCID: PMC1769655          DOI: 10.1136/jcp.55.5.355

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  24 in total

1.  Chlamydia pneumoniae serology: interlaboratory variation in microimmunofluorescence assay results.

Authors:  R W Peeling; S P Wang; J T Grayston; F Blasi; J Boman; A Clad; H Freidank; C A Gaydos; J Gnarpe; T Hagiwara; R B Jones; J Orfila; K Persson; M Puolakkainen; P Saikku; J Schachter
Journal:  J Infect Dis       Date:  2000-06       Impact factor: 5.226

Review 2.  Chlamydiae as pathogens: new species and new issues.

Authors:  R W Peeling; R C Brunham
Journal:  Emerg Infect Dis       Date:  1996 Oct-Dec       Impact factor: 6.883

3.  Chlamydia pneumoniae IgG titres and coronary heart disease: prospective study and meta-analysis.

Authors:  J Danesh; P Whincup; M Walker; L Lennon; A Thomson; P Appleby; Y Wong; M Bernardes-Silva; M Ward
Journal:  BMJ       Date:  2000-07-22

Review 4.  Chronic infection in the aetiology of atherosclerosis--focus on Chlamydia pneumoniae.

Authors:  S Gupta
Journal:  Atherosclerosis       Date:  1999-03       Impact factor: 5.162

5.  Interference of immunoglobulin G (IgG) antibodies in IgA antibody determinations of Chlamydia pneumoniae by microimmunofluorescence test.

Authors:  T Jauhiainen; T Tuomi; M Leinonen; J D Kark; P Saikku
Journal:  J Clin Microbiol       Date:  1994-03       Impact factor: 5.948

6.  Chlamydia pneumoniae community-acquired pneumonia: a review of 62 hospitalized adult patients.

Authors:  D Lieberman; M Ben-Yaakov; Z Lazarovich; A Porath; F Schlaeffer; D Lieberman; M Leinonen; P Saikku; O Horovitz; I Boldur
Journal:  Infection       Date:  1996 Mar-Apr       Impact factor: 3.553

7.  Chlamydia pneumoniae infection in patients with chronic obstructive pulmonary disease.

Authors:  L Von Hertzen; H Alakärppä; R Koskinen; K Liippo; H M Surcel; M Leinonen; P Saikku
Journal:  Epidemiol Infect       Date:  1997-04       Impact factor: 2.451

Review 8.  Chlamydia pneumoniae (TWAR).

Authors:  C C Kuo; L A Jackson; L A Campbell; J T Grayston
Journal:  Clin Microbiol Rev       Date:  1995-10       Impact factor: 26.132

9.  Antibodies to Chlamydia pneumoniae in healthy children from Bari, south Italy.

Authors:  R Monno; G Di Bitonto; L Marcuccio; M Valenza; C Marcuccio
Journal:  New Microbiol       Date:  1998-07       Impact factor: 2.479

10.  Clinical features of Chlamydia pneumoniae acute respiratory infection.

Authors:  Francesco Blasi
Journal:  Clin Microbiol Infect       Date:  1996-03       Impact factor: 8.067

View more
  2 in total

1.  A population based seroepidemiological survey of Chlamydia pneumoniae infections in schoolchildren.

Authors:  G Dal Molin; B Longo; T Not; A Poli; C Campello
Journal:  J Clin Pathol       Date:  2005-06       Impact factor: 3.411

2.  Respiratory infection caused by Chlamydophila pneumoniae in children and adolescents in the Lower Silesia Region of Poland.

Authors:  Irena Choroszy-Krol; I M Frej-Madrzak; D Teryks-Wolyniec; A Jama-Kmiecik; G Gosciniak; I Pirogowicz; M Pokorski
Journal:  Eur J Med Res       Date:  2010-11-04       Impact factor: 2.175

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.